×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Pre-Workshop Session: WHAT IS NEW IN THE CLINICAL TRIALS REGULATION – OVERWIEW OF THE KEY CHANGES
Speaker(s)
Clare Lavery, MSc
AstraZeneca, United Kingdom
Pharmacovigilance Excellence Principal
What is New in the Clinical Trials Regulation - Overview of the key changes
Fabienne Zeegers, DrSc, MSc
Bristol Myers Squibb International, Belgium
Director, Global Regulatory Sciences Liaison and Strategy
Have an account?